The effect of intravenous laser in burned patients

Investigation of the analgesic effects of intravenous laser in burned patients with grade 3 and b2 and higher than 20%

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111121008146N16

Enrollment

Registered

2018-01-02

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burn with grade 3 and b2 and higher than 20%. Bullous disorders

Interventions

Intervention 1: Intervention group: Patients in the laser group receive routine daily treatment for 1 week with intravenous laser with red light, 655 nm, 10 mW, 10 jules. Intervention 2: Control group

Treatment - Other

Placebo

Intervention group: Patients in the laser group receive routine daily treatment for 1 week with intravenous laser with red light, 655 nm, 10 mW, 10 jules.

Control group: They are treated with medicine plus non-therapeutic doses of shame laser.

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: patients aged 20-50 years patients with grade 3 and b2 burns with a higher than 20% informed consent

Exclusion criteria

Exclusion criteria: chronic patients with continuous onset drug use addicted people pregnant women Cancer patients

Design outcomes

Primary

Measure	Time frame
Pain score of patients. Timepoint: Three to five days after starting treatment every 3 hours. Method of measurement: McGill questionnaire scoring system and VAS mark.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mohammad Reza Razaghi

Laser Application Research Center in Medical Science

laser.cntr@yahoo.com+98 21 2274 9221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026